Rituximab

Rituximab · Anti-CD20 monoclonal antibody

DLBCL, follicular lymphoma, chronic lymphocytic leukemia and other hematologic malignancies

100mg/500mg IV infusion Insurance Category B

Therapeutic Areas

Oncology

Marketed Products

Rituximab

Modality

Rituximab

Core Products

Osimertinib · 3rd-generation EGFR TKI

Palbociclib · CDK4/6 inhibitor

Bevacizumab · Anti-VEGF monoclonal antibody

Creating a Healthier Future Together

Explore our innovative products and pipeline, and see how Poseidon brings hope to patients worldwide